Prudent Man Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Prudent Man Advisors, LLC

$263 Million
Q1 2024

A detailed history of Prudent Man Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 1,934 shares of VRTX stock, worth $939,904. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,934

Previous 2,057 5.98%

Holding current value

$939,904

Previous $836,000 3.35%

% of portfolio

0.31%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $50,145 - $54,867	-123 Reduced 5.98%	1,934 $808,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $10,290 - $12,320	-30 Reduced 1.44%	2,057 $836,000
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $24,010 - $25,734	-71 Reduced 3.29%	2,087 $725,000
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $9,432 - $10,557	-30 Reduced 1.37%	2,158 $759,000
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $7,080 - $8,077	-25 Reduced 1.13%	2,188 $689,000

Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $168,026 - $189,030	588 Added 36.18%	2,213 $639,000
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $3,285 - $3,666	-12 Reduced 0.73%	1,625 $471,000
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $6,578 - $8,191	-28 Reduced 1.68%	1,637 $461,000
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $13,063 - $15,397	-59 Reduced 3.42%	1,665 $435,000
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $531 - $670	-3 Reduced 0.17%	1,724 $379,000
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $3,809 - $4,262	-21 Reduced 1.2%	1,727 $313,000
Q2 2021 Aug 03, 2021	BUY	$187.49 - $221.1 $9,936 - $11,718	53 Added 3.13%	1,748 $352,000
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $17,182 - $20,028	83 Added 5.15%	1,695 $364,000
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $6,417 - $8,558	-31 Reduced 1.89%	1,612 $381,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $13,805 - $16,367	54 Added 3.4%	1,643 $447,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $358,287 - $470,026	1,589 New	1,589 $461,000

Others Institutions Holding VRTX

# of Institutions

1,625

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudent Man Advisors, LLC with notifications on news.

Account

Prudent Man Advisors, LLC Vertex Pharmaceuticals Inc Transaction History